Evaluation of Antioxidant-Rich Mexican Oregano (Lippia graveolens) Infusion and Carvacrol: Impact on Metabolic Activity and Cytotoxicity in Breast Cancer Cell Lines
Nutrients · 28.09.2025 · 17 (19) · 3089
DOI: 10.3390/nu17193089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 28.09.2025. Verfasst von Brian Enrique Rojo-Ruvalcaba und 10 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Doctorado en Ciencias en Biología Molecular en Medicina, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias …. Hauptthemen laut MEDLINE: Cymenes, Lippia, Antioxidants, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Boots Project Fund, Program for improving the production of people in the National Research System.
Abstract (Originalsprache)
Background/Objectives: The search for natural alternatives in breast cancer (BC) management has spurred interest in plant-derived extracts, particularly oregano variants and their bioactive compound carvacrol (Cv). However, Mexican oregano (Lippia graveolens) infusion (MoI) remains unexplored. This study aimed to chemically characterize MoI and compare its anticancer effects with Cv across BC cell lines, including aggressive triple-negative (TN) subtypes.
Methods
MoI was analyzed for composition, antioxidant capacity (ABTS, DPPH, FRAP, total phenols/flavonoids), and phytochemical profile (FTIR, HPLC). Anticancer activity was assessed via MTT and LDH assays.
Results
MoI exhibits strong antioxidant capacity and concentration-dependent antiproliferative effects, with IC50 values ranging from 0.08 to 0.18 mg/mL across BC lines, significantly higher (i.e., less cytotoxic) than Cv IC50 of 121–211 µM. Importantly, MoI displayed markedly lower cytotoxicity toward non-cancerous cells (IC50 0.18 mg/mL) compared to Cv (IC50 110 µM).
Conclusions
While both agents reduced metabolic activity, Cv induced a more acute suppression. These findings position MoI as a promising, selective candidate for BC therapy, particularly for poor-prognosis subtypes like TN BC, warranting further mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Programa de Doctorado en Ciencias en Biología Molecular en Medicina, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jal…
- Centro de Investigación en Enfermedades Infectocontagiosas (CIEIC), Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco,…
- Instituto de Cáncer en la Infancia y la Adolescencia (INICIA), Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
- Instituto de Investigaciones en Comportamiento Alimentario y Nutrición (IICAN), Centro Universitario del Sur (CUSUR), Universidad de Guadalajara, Ciudad Guzmán 49000, Jalisco, Mexico.
- Tecnológico Nacional de México-Instituto Tecnológico de Tlajomulco, DEPI, Tlajomulco de Zúñiga 45640, Jalisco, Mexico.
- Instituto de Terapéutica Experimental y Clínica (INTEC), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
ORCID-Profile: Brian Enrique Rojo-Ruvalcaba, Montserrat Maldonado-González, Gabriela María Cálix-Rodríguez, Elia Herminia Valdés-Miramontes, Juan Florencio Gómez-Leyva, Andrea Carolina Machado-Sulbaran, Rocío Ivette López-Roa, Iván Balderas-León, Trinidad García-Iglesias
Förderung
- Research Boots Project Fund
- Program for improving the production of people in the National Research System
Zitieren
APA
Rojo-Ruvalcaba, B. E., Maldonado-González, M., Cálix-Rodríguez, G. M., Valdés-Miramontes, E. H., Gómez-Leyva, J. F., García-Cobián, T. A., Sánchez-Hernández, P. E., Machado-Sulbaran, A. C., López-Roa, R. I., Balderas-León, I., & García-Iglesias, T. (2025). Evaluation of Antioxidant-Rich Mexican Oregano (Lippia graveolens) Infusion and Carvacrol: Impact on Metabolic Activity and Cytotoxicity in Breast Cancer Cell Lines. Nutrients, 17(19), 3089. https://doi.org/10.3390/nu17193089
Vancouver
Rojo-Ruvalcaba BE, Maldonado-González M, Cálix-Rodríguez GM, Valdés-Miramontes EH, Gómez-Leyva JF, García-Cobián TA, et al. Evaluation of Antioxidant-Rich Mexican Oregano (Lippia graveolens) Infusion and Carvacrol: Impact on Metabolic Activity and Cytotoxicity in Breast Cancer Cell Lines. Nutrients. 2025;17(19):3089. doi:10.3390/nu17193089
BibTeX
@article{RojoRuvalcaba2025,
author = {Rojo-Ruvalcaba, Brian Enrique and Maldonado-González, Montserrat and Cálix-Rodríguez, Gabriela María and Valdés-Miramontes, Elia Herminia and Gómez-Leyva, Juan Florencio and García-Cobián, Teresa Arcelia and Sánchez-Hernández, Pedro Ernesto and Machado-Sulbaran, Andrea Carolina and López-Roa, Rocío Ivette and Balderas-León, Iván and García-Iglesias, Trinidad},
title = {Evaluation of Antioxidant-Rich Mexican Oregano (Lippia graveolens) Infusion and Carvacrol: Impact on Metabolic Activity and Cytotoxicity in Breast Cancer Cell Lines},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {19},
pages = {3089},
doi = {10.3390/nu17193089}
}
EUVIMED